Whilst the absolute concentrations are not directly comparable with the COVID-19 cohort (as the samples were plasma rather than serum), GFAP and NfL were elevated in patients with severe disease to a similar magnitude as the COVID-19 cohort (Supplementary Fig. 4D). This evidence concerns the gene GFAP and COVID-19.